Spectral CT to check for heart damage from lymphoma treatment
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study uses a special type of CT scan called spectral CT to see if chemotherapy drugs called anthracyclines can cause heart damage in people with certain lymphomas. The goal is to catch any heart problems early by imaging the heart before, during, and after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have either Hodgkin's lymphoma or diffuse large B-cell lymphoma
- You must be 18 years old or older
- You must be getting or will be getting chemotherapy with anthracycline drugs (like doxorubicin)
- You cannot have a severe allergy to CT contrast dye, serious kidney problems, or be pregnant
- You cannot have a history of heart disease (like a heart attack, heart failure, or irregular heartbeats)
- You cannot have had radiation therapy to your chest area
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special CT scan (called spectral CT) to look for inflammation of the heart muscle or other heart problems in people who come to the hospital with sudden chest pain. The goal is to see if this scan can help doctors diagnose the cause of your chest pain more accurately.
This trial tests if a heart-protecting drug (dexrazoxane) can prevent heart damage in people getting chemotherapy for certain types of large B-cell lymphoma. It is for patients who already have heart risk factors or a history of heart failure.
This trial studies whether a simple “remote conditioning” treatment on the arm can help protect the heart while you receive chemotherapy that includes anthracyclines. If you’re at higher risk for heart damage from chemo, this may reduce risk and help monitor heart function over time.
This study uses a special high-resolution CT scan to look at heart and lung problems in people with a type of lung disease that gets worse over time. It may help doctors understand how the heart is affected and guide better care.
This trial checks how anthracycline chemotherapy affects the heart and blood vessels in children and teens who had cancer. It aims to help doctors better understand long-term heart risks and follow-up care.
This study looks at how certain blood-related “growth patterns” connect to long-term heart health after treatment for classical Hodgkin lymphoma. It may help doctors better predict who could develop heart problems and how to monitor them over time.
Hear when a new Cardiac Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.